Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4063302
Max Phase: Preclinical
Molecular Formula: C9H10ClN3
Molecular Weight: 195.65
Molecule Type: Small molecule
Associated Items:
ID: ALA4063302
Max Phase: Preclinical
Molecular Formula: C9H10ClN3
Molecular Weight: 195.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: ClCCCn1nc2ccccc2n1
Standard InChI: InChI=1S/C9H10ClN3/c10-6-3-7-13-11-8-4-1-2-5-9(8)12-13/h1-2,4-5H,3,6-7H2
Standard InChI Key: PVWHVZAKXREYBM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 195.65 | Molecular Weight (Monoisotopic): 195.0563 | AlogP: 2.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.21 | CX LogD: 2.21 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.70 | Np Likeness Score: -1.23 |
1. Singh D, Silakari O.. (2017) Sodium hydrogen exchanger inhibitory activity of benzotriazole derivatives., 126 [PMID:27750152] [10.1016/j.ejmech.2016.10.005] |
Source(1):